Workflow
*ST长药: 第五届董事会第二十七次会议决议公告

Group 1 - The board of directors of Changjiang Pharmaceutical Holdings Co., Ltd. held its 27th meeting on July 3, 2025, via on-site and remote voting due to urgent circumstances [1][2] - All 9 participating directors voted in favor of the proposal, with no votes against or abstentions, resulting in the proposal being approved [1][2] - The proposal will be submitted for shareholder meeting review, with additional notifications regarding the cancellation of certain sub-proposals and the addition of new temporary proposals [2] Group 2 - The meeting was convened by Mr. Wang Bo, who provided explanations regarding the urgent nature of the meeting [1] - The procedures and methods for convening the meeting complied with relevant laws, regulations, and the company's articles of association [1] - The board's nomination committee reviewed and approved the proposal prior to the meeting [1]